Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dayglim M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Daylon Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Dayglim M 1mg/500mg Tablet

GlucoTone Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Administer GlucoTone Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is vital; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan that includes diet, exercise, and weight control as directed by your doctor. Lifestyle choices are crucial in diabetes management. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Dayglim M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Dayglim M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Dayglim M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Dayglim M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dayglim M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Dayglim M 1mg/500mg Tablet with a meal.

How Dayglim M 1mg/500mg Tablet works:

Dayglim M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Dayglim M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dayglim M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Dayglim M 1mg/500mg tablets due to the potential for infant harm from the medication's toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dayglim M 1mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Dayglim M 1mg/500mg Tablet use. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dayglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate liver disease, treatment typically begins with a reduced Dayglim M 1mg/500mg tablet dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Dayglim M 1mg/500mg Tablet :

Should you forget a Dayglim M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dayglim M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dayglim M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dayglim M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Dayglim M 1mg/500mg Tablets and seek immediate medical attention.
Dayglim M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Dayglim M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Dayglim M 1mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dayglim M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dayglim M 1mg/500mg tablets and alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Dayglim M 1mg/500mg Table...
52
MRP 60
13% off